2009
DOI: 10.1086/605477
|View full text |Cite
|
Sign up to set email alerts
|

New Developments with Vancomycin‐Resistant Enterococci:E. faecium—Friend or Foe?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2012
2012
2012
2012

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 23 publications
0
1
0
1
Order By: Relevance
“…Currently, about 70 % of E. faecium isolates in US hospitals are vancomycin resistant while 90 % are ampicillin resistant. In contrast, very few E. faecalis (1-5 %) are resistant to either of these antibiotics, which probably explains the increase of E. faecium relative to E. faecalis in the hospital setting where antibiotics active against E. faecalis are frequently used (Hidron et al, 2008;Bertics et al, 2009). …”
Section: Introductionmentioning
confidence: 99%
“…Currently, about 70 % of E. faecium isolates in US hospitals are vancomycin resistant while 90 % are ampicillin resistant. In contrast, very few E. faecalis (1-5 %) are resistant to either of these antibiotics, which probably explains the increase of E. faecium relative to E. faecalis in the hospital setting where antibiotics active against E. faecalis are frequently used (Hidron et al, 2008;Bertics et al, 2009). …”
Section: Introductionmentioning
confidence: 99%
“…O papel de terapia combinada como uma opção à ineficiente monoterapia ainda não foi estabelecido, tanto in vitro quanto em modelo animal 27 . Staphylococcus spp, de transposons codificadores de resistência a vancomicina, com um grande impacto nas infecções relacionadas à assistência à saúde 43 .…”
Section: Quadrounclassified